Healthy volunteers test new combo Pill's absorption
NCT ID NCT07141511
First seen Nov 17, 2025 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This study tested a new fixed-dose combination tablet containing two drugs, zanubrutinib and sonrotoclax, in 24 healthy adults. The goal was to see how well the body absorbs the combo pill compared to taking the drugs separately, and whether food changes absorption. Participants took single doses under different conditions, and researchers measured drug levels and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Early Phase
Joondalup, Western Australia, WA 6027, Australia
Conditions
Explore the condition pages connected to this study.